Atlas Trials

Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis

Clinical trial NCT03450083 · COMPLETED

Trial details

NCT number
NCT03450083
Sponsor
Johns Hopkins University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Rhinosinusitis (Diagnosis)Nasal PolypsEosinophilia
Start date
2017-07-01
Primary completion
2020-01-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.